Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate

Por um escritor misterioso

Descrição

Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
p38 mitogen‐activated protein kinase: Functions and targeted
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
PDF) Pyrazolo-pyrimidines: A novel heterocyclic scaffold for
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Current status and future prospects of p38α/MAPK14 kinase and its
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
New modifications to the area of pyrazole-naphthyl urea based p38
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
PDF) The design and synthesis of novel α-ketoamide-based p38 MAP
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Structure-based design, synthesis and biological evaluation of N
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Figure 1 from 'Reverse' alpha-ketoamide-based p38 MAP kinase
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Full article: p38 MAPK inhibitors: a patent review (2012 – 2013)
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Frontiers Urea-based anticancer agents. Exploring 100-years of
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Molecules, Free Full-Text
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
p38 MAP kinases: key signalling molecules as therapeutic targets
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Full article: The p38 MAPK inhibitor BIRB796 enhances the
de por adulto (o preço varia de acordo com o tamanho do grupo)